Endocrinoloxía e nutrición

1998

1. @?SIGUE SIENDO VALIDA LA CARDIOPLEJIA CRISTALOIDE COMO TECNICA DE PROTECCION MIOCARDICA?

   Revista Espanola de Anestesiologia y Reanimacion, Vol. 45, Núm. 1, pp. 12-16

2. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels

   Journal of Endocrinological Investigation, Vol. 21, Núm. 8, pp. 526-530

3. Both a reduced acute insulin response to glucose and lower glucose effectiveness are responsible for the worsening of intravenous glucose tolerance in healthy subjects independently of the degree of obesity

   Metabolism: Clinical and Experimental, Vol. 47, Núm. 3, pp. 313-320

4. Central diabetes insipidus secondary to infundibuloneurohypophysitis

   Anales de medicina interna (Madrid, Spain : 1984), Vol. 15, Núm. 12, pp. 658-660

5. Cis-unsaturated Free Fatty Acids Block VIP-mediated GH and PRL Secretion by Perturbing the cAMP/Protein Kinase a Pathway

   Pituitary, Vol. 1, Núm. 1, pp. 25-32

6. Early detection and control of risk factors in diabetic nephropathy

   Anales de medicina interna (Madrid, Spain : 1984), Vol. 15, Núm. 11, pp. 600-605

7. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism

   Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 12, pp. 4350-4354

8. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (octreoscan)

   Experimental and Clinical Endocrinology and Diabetes, Vol. 106, Núm. 3, pp. 226-230

9. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome

   Clinical Endocrinology, Vol. 48, Núm. 1, pp. 117-121

10. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: Dexamethasone and estradiol stimulate leptin release in women, but not in men

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 6, pp. 2149-2155

11. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy

    Clinical Endocrinology, Vol. 48, Núm. 1, pp. 103-108

12. Interaction between body composition, leptin and growth hormone status

    Bailliere's Clinical Endocrinology and Metabolism, Vol. 12, Núm. 2, pp. 297-314

13. Interaction between leptin and neuropeptide Y on in vivo growth hormone secretion

    Neuroendocrinology, Vol. 68, Núm. 3, pp. 187-191

14. Isolation of a bioactive Ca2+-mobilizing complex lipid from bovine vitreous body

    Biochemical and Biophysical Research Communications, Vol. 244, Núm. 3, pp. 696-700

15. La administracion por via oral de dosis bajas de growth hormone releasing hexapeptide-6-mas piridostigmina es un estimulo adecuado de la secrecion de GH

    Endocrinologia, Vol. 45, Núm. 10, pp. 341-344

16. Minimal model of glucose metabolism: Modified equations and its application in the study of insulin sensitivity in obese subjects

    Diabetes Research and Clinical Practice, Vol. 39, Núm. 2, pp. 129-141

17. Non-insulin-mediated glucose uptake in several insulin-resistant states in the postabsortive period

    Diabetes Research and Clinical Practice, Vol. 39, Núm. 2, pp. 107-113

18. PMA inhibits both spontaneous and glucocorticoid-mediated leptin secretion by human omental adipose tissue explants in vitro

    Biochemical and Biophysical Research Communications, Vol. 252, Núm. 2, pp. 345-347

19. Preserved growth hormone (GH) secretion in aged and very old subjects after testing with the combined stimulus GH-releasing hormone plus GH- releasing hexapeptide-6

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 7, pp. 2569-2572

20. Prevalencia de la obesidad en España: Estudio SEEDO'97

    Medicina Clinica, Vol. 111, Núm. 12, pp. 441-445